The conclusions reached were the same as the previous analysis and showed that the expression of ITGAL in prostate cancer, thyroid cancer, bladder cancer, lung squamous cell carcinoma, and lung adenocarcinoma are highly expressed in adjacent cancer tissues, on the other hand, ovarian cancer, renal clear cell carcinoma, and cervical cancer are highly expressed in cancer tissues Table 2. Here, ITGAL is linked to prostate cancer.